ipragliflozin: Clinical Trials

1 trial of ipragliflozin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Terminated 1

Follow ipragliflozin: new trials by email Literature Review of ipragliflozin trials Research Report on ipragliflozin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
metformin, ipragliflozin, glimepiride - Type 2 Diabetes Mellitus
Phase 4TerminatedAstellas Pharma Korea, Inc.332017-04-252024-11-08

Conditions studied

Diabetes Mellitus, Type 2 (1)

Sponsors

Astellas Pharma Korea, Inc. (1)

Countries

South Korea (1)